Hilleman Jeryl L insider trades
Hilleman Jeryl L has filed 34 Form 4s with the SEC that we hold, for Omada Health, Inc. (OMDA) (Director), NovoCure Ltd (NVCR) (Director), SI-BONE, Inc. (SIBN) (Director) and HLVX (Director), among 6 companies in all. Across all of them we count 0 purchases worth $0 and 6 sales worth $236.7K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($46.4K). The largest single trade was a sale of 2,081 shares of SI-BONE, Inc. worth $59.8K, dated 2023-06-15. The first filing on our record is dated 2022-06-10 and the latest 2026-10-07.
Omada Health, Inc. (OMDA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
NovoCure Ltd (NVCR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-06-10 | S, sale reported on Form 4 | 407 | $28.3K | 2022-06-16 |
| 2025-06-03 | S, sale reported on Form 4 | 999 | $17.2K | 2025-06-04 |
| 2026-06-02 | S, sale reported on Form 4 | 2,945 | $46.4K | 2026-06-03 |
SI-BONE, Inc. (SIBN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-06-13 | S, sale reported on Form 4 | 1,924 | $26.6K | 2022-06-14 |
| 2023-06-15 | S, sale reported on Form 4 | 2,081 | $59.8K | 2023-06-20 |
| 2023-06-20 | S, sale reported on Form 4 | 2,081 | $58.3K | 2023-06-20 |
HLVX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CUTR
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Minerva Neurosciences, Inc. (NERV)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1216628) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms